Yuan-Yeh Kuo (Yu-Hung Wang)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Chronic Kidney Disease

Top Venues

American journal of hematology

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Shan-Chi Yu, Ming-Chih Liu, Chang-Tsu Yuan, Yi-Tsung Yang, Ming-Kai Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Hwei-Fang Tien, Hsin-An Hou, Wen-Chien Chou
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms. Blood cancer journal 14 (1) (2024)
Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Shan-Chi Yu, Ming-Chih Liu, Chang-Tsu Yuan, Yi-Tsung Yang, Ming-Kai Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Hwei-Fang Tien, Hsin-An Hou, Wen-Chien Chou
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms. Blood cancer journal 14 (1) (2024)
Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Shan-Chi Yu, Ming-Chih Liu, Chang-Tsu Yuan, Yi-Tsung Yang, Ming-Kai Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Hwei-Fang Tien, Hsin-An Hou, Wen-Chien Chou
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms. Blood cancer journal 14 (1) (2024)
Chien-Chin Lin, Chi-Yuan Yao, Yuan-Yeh Kuo, Yueh-Chwen Hsu, Chang-Tsu Yuan, Tsung-Chih Chen, Chia-Lang Hsu, Sze-Hwei Lee, Jhih-Yi Lee, Pin-Tsen Shih, Chein-Jun Kao, Po-Han Chuang, Yuan-Yeh Kuo, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien
IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo. EJHaem 5 (4) (2024)
Chien-Chin Lin, Chi-Yuan Yao, Yuan-Yeh Kuo, Yueh-Chwen Hsu, Chang-Tsu Yuan, Tsung-Chih Chen, Chia-Lang Hsu, Sze-Hwei Lee, Jhih-Yi Lee, Pin-Tsen Shih, Chein-Jun Kao, Po-Han Chuang, Yuan-Yeh Kuo, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien
IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo. EJHaem 5 (4) (2024)
Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Sao-Chih Ni, Ming Yao, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Ming-Chih Liu, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification. American journal of hematology 98 (3) (2023)
Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Sao-Chih Ni, Ming Yao, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Ming-Chih Liu, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification. American journal of hematology 98 (3) (2023)
Min-Yen Lo, Xavier Cheng-Hong Tsai, Chien-Chin Lin, Feng-Ming Tien, Yuan-Yeh Kuo, Wan-Hsuan Lee, Yen-Ling Peng, Ming-Chih Liu, Mei-Hsuan Tseng, Cheng-An Hsu, Jui-Che Chen, Liang-In Lin, Hsun-I Sun, Yi-Kuang Chuang, Bor-Sheng Ko, Jih-Luh Tang, Ming Yao, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia. American journal of hematology (2023)
Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Sao-Chih Ni, Ming Yao, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Ming-Chih Liu, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification. American journal of hematology 98 (3) (2023)
Wan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Ming-Chih Liu, Yi-Tsung Yang, Jui-Che Chen, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Liang-In Lin, Wen-Chien Chou, Chien-Chin Lin, Hsin-An Hou, Hwei-Fang Tien
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification. Blood cancer journal 13 (1) (2023)
Min-Yen Lo, Xavier Cheng-Hong Tsai, Chien-Chin Lin, Feng-Ming Tien, Yuan-Yeh Kuo, Wan-Hsuan Lee, Yen-Ling Peng, Ming-Chih Liu, Mei-Hsuan Tseng, Cheng-An Hsu, Jui-Che Chen, Liang-In Lin, Hsun-I Sun, Yi-Kuang Chuang, Bor-Sheng Ko, Jih-Luh Tang, Ming Yao, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia. American journal of hematology (2023)
Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Sao-Chih Ni, Ming Yao, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Ming-Chih Liu, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification. American journal of hematology 98 (3) (2023)
Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Sao-Chih Ni, Ming Yao, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Ming-Chih Liu, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification. American journal of hematology (2023)
Wan-Hsuan Lee, Chien-Chin Lin, Yu-Hung Wang, Chi-Yuan Yao, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Cheng-An Hsu, Hsun-I Sun, Yi-Kuang Chuang, Chia-Lang Hsu, Feng-Ming Tien, Cheng-Hong Tsai, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes. Hematological oncology (2022)
Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Ming-Chih Liu, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Effect of mutation allele frequency on the risk stratification of myelodysplastic syndrome patients. American journal of hematology 97 (12) (2022)
Yu-Hung Wang, Hsin-An Hou, Chien-Chin Lin, Yuan-Yeh Kuo, Chi-Yuan Yao, Chia-Lang Hsu, Mei-Hsuan Tseng, Xavier Cheng-Hong Tsai, Yen-Ling Peng, Chein-Jun Kao, Wen-Chien Chou, Hwei-Fang Tien
A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes. Blood advances 5 (22) (2021)
Xavier Cheng-Hong Tsai, Jih-Luh Tang, Feng-Ming Tien, Yuan-Yeh Kuo, Dung-Chi Wu, Chien-Chin Lin, Mei-Hsuan Tseng, Yen-Ling Peng, Mei-Fang Hou, Yi-Kuang Chuang, Ming-Chih Liu, Chia-Wen Liu, Ming Yao, Liang-In Lin, Wen-Chien Chou, Chien-Yu Chen, Hsin-An Hou, Hwei-Fang Tien
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML. Blood advances 5 (10) (2021)
Yu-Hung Wang, Chien-Chin Lin, Sze-Hwei Lee, Xavier Cheng-Hong Tsai, Shan-Ju Wu, Hsin-An Hou, Tai-Chung Huang, Yuan-Yeh Kuo, Ming Yao, Koping Chang, Chung-Wu Lin, Yun-Chu Lin, Feng-Ming Tien, Wen-Chien Chou, Jih-Luh Tang, Hwei-Fang Tien
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden. Blood cancer journal 10 (10) (2020)
Pei-Shan Hung, Ming-Hung Huang, Yuan-Yeh Kuo, James Chih-Hsin Yang
The Inhibition of Wnt Restrain KRASG12V-Driven Metastasis in Non-Small-Cell Lung Cancer. Cancers 12 (4) (2020)
Hsin-An Hou, Xavier Cheng-Hong Tsai, Chien-Chin Lin, Wen-Chien Chou, Yuan-Yeh Kuo, Chieh-Yu Liu, Mei-Hsuan Tseng, Yen-Ling Peng, Ming-Chih Liu, Chia-Wen Liu, Xiu-Wen Liao, Liang-In Lin, Ming Yao, Jih-Luh Tang, Hwei-Fang Tien
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome. Blood cancer journal 8 (4) (2018)
Xavier Cheng-Hong Tsai, Hsin-An Hou, Jih-Luh Tang, Yuan-Yeh Kuo, Yu-Chiao Chiu, Chien-Chin Lin, Chieh-Yu Liu, Mei-Hsuan Tseng, Tzung-Yi Lin, Ming-Chih Liu, Chia-Wen Liu, Liang-In Lin, Ming Yao, Chi-Cheng Li, Shang-Yi Huang, Bor-Sheng Ko, Szu-Chun Hsu, Chien-Ting Lin, Shang-Ju Wu, Chien-Yuan Chen, Woei Tsay, Eric Y Chuang, Wen-Chien Chou, Hwei-Fang Tien
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia. Blood cancer journal 7 (12) (2017)